Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • ENT (3)
  • Immunomodulation and nutrition (3)
  • Mastocytosis and mast cells (11)
  • Systems medicine (1)
Poster available until
  • Until platform closure (1)
Poster categories
  • Thematic Poster Session (28)
keywords
Session Reference
  • L-TPS01 (11)
  • L-TPS02 (15)
  • L-TPS03 (14)
  • L-TPS04 (12)
  • L-TPS05 (13)
  • L-TPS06 (8)
  • L-TPS07 (11)
  • L-TPS08 (7)
  • L-TPS09 (13)
  • L-TPS10 (13)
  • L-TPS11 (12)
  • L-TPS12 (14)
  • L-TPS13 (13)
  • L-TPS14 (11)
  • L-TPS15 (7)
  • L-TPS16 (14)
  • L-TPS17 (13)
  • L-TPS18 (10)
  • L-TPS19 (10)
  • L-TPS20 (12)
  • L-TPS21 (12)
  • TPS01 (12)
  • TPS02 (8)
  • TPS03 (14)
  • TPS04 (9)
  • TPS05 (15)
  • TPS06 (11)
  • TPS07 (13)
  • TPS08 (9)
  • TPS09 (9)
  • TPS10 (16)
  • TPS11 (13)
  • TPS12 (12)
  • TPS13 (11)
  • TPS14 (12)
  • TPS15 (15)
  • TPS16 (15)
  • TPS17 (12)
  • TPS18 (10)
  • TPS19 (7)
  • TPS20 (11)
  • TPS21 (5)
  • TPS22 (3)
  • TPS23 (4)
  • TPS25 (12)
  • TPS26 (14)
  • TPS27 (12)
  • TPS28 (16)
  • TPS29 (16)
  • TPS30 (14)
  • TPS31 (15)
  • TPS32 (16)
  • TPS33 (14)
  • TPS34 (17)
  • TPS35 (15)
  • TPS36 (12)
  • TPS37 (15)
  • TPS38 (13)
  • TPS39 (14)
  • TPS40 (13)
  • TPS41 (9)
  • TPS42 (12)
  • x TPS43 (12)
  • TPS44 (14)
  • TPS45 (12)
  • TPS46 (8)
  • TPS47 (7)
  • TPS48 (5)
  • x TPS49 (5)
  • TPS51 (12)
  • TPS52 (14)
  • TPS53 (8)
  • TPS54 (15)
  • TPS55 (13)
  • TPS56 (16)
  • TPS57 (12)
  • TPS58 (12)
  • TPS59 (13)
  • TPS60 (14)
  • TPS61 (11)
  • TPS62 (9)
  • TPS63 (10)
  • TPS64 (11)
  • TPS65 (8)
  • TPS66 (9)
  • TPS67 (9)
  • TPS68 (19)
  • TPS69 (8)
  • TPS70 (9)
  • x TPS71 (11)
  • TPS72 (6)
  • TPS73 (5)
  • TPS75 (4)
28 results
Thumbnail

D2.366 - The establishment of a Japanese cypress pollen environmental exposure chamber protocol

Thumbnail

D2.367 - Omalizumab Efficacy in Relapse of Nasal Polyposis

Thumbnail

D2.368 - Lack of anaerobic gut bacteria in patients with aspirin intolerance and allergy

Thumbnail

D2.369 - Impaired Retinoic Acid Metabolism and Eotaxin Overexpression in Eosinophilic Chronic Rhinosinusitis: Insights into Pathophysiology and Therapeutic Potential of CRABP1 Targeting

Thumbnail

D2.370 - Trends in Sensitization to Pet Allergens and Correlation between Symptoms and Asthma in Allergic Rhinitis from 2017 to 2023 in China

Thumbnail

D2.372 - Evaluating ChatGPT's Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis

Thumbnail

D2.374 - Smoking increases mortality risk of chronic inflammatory airway diseases: a real-world hospital cohort study

Thumbnail

D2.375 - Concomitant allergic and ENT pathology in children with chronic inflammatory diseases

Thumbnail

D2.376 - The role of endoscopic sinus surgery in chronic rhinosinusitis with minimally affected computed tomography

Thumbnail

D2.378 - Exploring the Connection Between Allergic Rhinitis and Sinusitis in Children

Thumbnail

D2.371 - Clinical Implication of Neutrophil Phenotypes in Chronic Rhinosinusitis With Nasal Polyps

Thumbnail

D2.373 - Diurnal variation in Japanese cedar pollinosis symptoms

Thumbnail

D2.437 - Long-Term Analysis of the Phase 2 Open-Label Extension of Donidalorsen in Patients With Hereditary Angioedema

Thumbnail

D2.436 - Application Study on the prevention and treatment of spleen aminopeptide oral solution on seasonal allergic rhinitis

Thumbnail

D2.438 - Adipose-derived stem cells secretome attenuates eosinophilic inflammation in a chronic rhinosinusitis with nasal polyps mouse model

Thumbnail

D2.439 - Low vitamin D levels in patients with allergic rhinitis and its supplementation

Thumbnail

D2.440 - Burden of disease and patient preference in Hereditary Angioedema: findings from a mixed methods survey of carers and patients in the United Kingdom

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Pagination

  • Current page 1
  • Page 2
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM